KAVANAGH SARAH B
SEC insider (Form 3/4/5 filer). CIK 0001681171. Director at Bausch & Lomb Corp (BLCO) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on May 26, 2026. Located in BRIDGEWATER, NJ.
Companies KAVANAGH SARAH B has filed insider reports for
- Bausch & Lomb Corp (BLCO): Director
- Bausch Health Companies Inc. (BHC): Director
KAVANAGH SARAH B
CIK: 0001681171
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- May 26, 2026BLCO
Bausch & Lomb Corp
AwardDirect15.8K shares at avg. $15.78$250K - May 22, 2026BHC
Bausch Health Companies Inc.
AwardDirect45.9K shares- - May 27, 2025BLCO
Bausch & Lomb Corp
AwardDirect20.3K shares- - May 16, 2025BHC
Bausch Health Companies Inc.
AwardDirect54.3K shares-
1-4 of 4 transactions